Chemi-Verse™ CDK14/Cyclin Y Kinase Assay Kit

Catalog #
78889
$1,350 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The Chemi-Verse™ CDK14/Cyclin Y Kinase Assay Kit is a luminescent assay designed to measure CDK14 (cyclin-dependent kinase 14)/Cyclin Y kinase activity for screening and profiling applications using ADP-Glo™ as a detection reagent. The assay kit comes in a convenient 96-well format, with enough purified recombinant CDK14/Cyclin Y complex, kinase substrate, ATP, and kinase assay buffer for 100 enzyme reactions.

Synonyms
Cell division protein kinase 14, Serine/threonine-protein kinase PFTAIRE-1 (hPFTAIRE1), KIAA0834, PFTK1, Cyclin-dependent kinase 14, C10orf9, CBCP1, CFP1, Cyclin box protein 1, Cyclin fold protein 1, cyclin-X, CDK-14
Product Info
Storage and Usage
Citations
Assay Kit Format
Luminescent
Materials Required But Not Supplied
  • ADP-Glo™ Kinase Assay (Promega #V6930)
  • DTT (Dithiothreitol), 1M, optional
  • Microplate reader capable of reading luminescence
  • Adjustable micropipettor and sterile tips
  • 30°C incubator
Format
Catalog # Name Amount Storage
100602 CDK14/Cyclin Y, GST-Tag* 20 µg -80°C
79334 5x Kinase Assay Buffer 1 1.5 ml -20°C
79686 500 µM ATP 50 µl -20°C
79604 5x CDK Substrate Peptide 2 250 µl -20°C
79696 White 96-well plate 1 Room Temp

*The concentration of the protein is lot-specific and will be indicated on the tube.

UniProt #
CDK14: O94921; Cyclin Y: Q8ND76
Background

CDK14 (cyclin dependent kinase 14) is a member of the cyclin-dependent protein kinase family involved in cell cycle, transcription and splicing.  CDK associates with cyclins, which induce a conformational change that results in a dramatic increase of kinase activity. Cyclin levels vary during the cell cycle, allowing cyclins to regulate CDK activity in the cell. Dissociation of the complex returns CDK to its basal activity, and CDK is degraded by ubiquitin mediated proteolysis. CDK16 plays a role in signaling, such as in the Wnt pathway. It has been categorized as an oncoprotein involved in several cancer types (such as non-small cell lung cancer, where can be used as a prognosis marker). The understanding of the mechanisms involved in cell cycle regulation, and its control via the use of small molecule inhibitors and micro-RNAs will open new therapeutic avenues for the treatment of cancer.